Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015

Michelle M. O’Shaughnessy1,2,3, Susan L. Hogan1, Caroline J. Poulton1, Ronald J. Falk1,3, Harsharan K. Singh1,3, Volker Nickeleit1,3, J. Charles Jennette1,3
1Division of Nephrology, Department of Medicine and the Kidney Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina; and
2Division of Nephrology, Stanford University School of Medicine, Palo Alto, California
3Division of Nephropathology, Department of Pathology and Laboratory Medicine, and

Tóm tắt

Background and objectives

Large-scale, contemporary studies exploring glomerular disease epidemiology in the United States are lacking. We aimed to determine 30-year temporal and demographic trends in renal biopsy glomerular disease diagnosis frequencies in the southeastern United States.

Design, setting, participants, & measurements

In this cross-sectional, observational study, we identified all patients with a native kidney biopsy specimen showing one of 18 widely recognized glomerular disease diagnoses referred to the University of North Carolina Chapel Hill Division of Nephropathology between 1986 and 2015. Biopsy era (1986–1995, 1996–2005, and 2006–2015) and demographics (age, sex, and race) were our primary and secondary predictors, respectively, and the relative frequency of each glomerular disease diagnosis was our primary outcome.

Results

Among 21,374 patients (mean age =48.3±18.3 years old; 50.8% men; 56.8% white; 38.3% black; 2.8% Latino; 1.4% Asian; 0.8% other), the frequency of diabetic glomerulosclerosis in renal biopsy specimens increased dramatically over the three decades (5.5%, 11.4%, and 19.1% of diagnoses, respectively; P for trend <0.001). The frequency of FSGS initially increased but then declined (22.6%, 27.2%, and 24.7%, respectively; P for trend =0.64). The frequencies of other common glomerular disease subtypes remained stable (IgA nephropathy and ANCA/pauci-immune GN) or declined (minimal change disease, membranous nephropathy, membranoproliferative GN, and lupus nephritis). These temporal trends were largely preserved within all demographic subgroups, although cross-sectional frequency distributions differed according to age, sex, and race.

Conclusions

We identified significant changes in relative renal biopsy frequencies of many glomerular disease subtypes over three decades. Temporal trends were consistently observed within all major demographic groups, although relative predominance of individual glomerular disease subtypes differed according to patient age, sex, and race. We propose that exploration of behavioral and environmental exposures that likely underlie these findings should be the focus of future hypothesis-driven research.

Từ khóa


Tài liệu tham khảo

Genovese, 2010, Association of trypanolytic ApoL1 variants with kidney disease in African Americans., Science, 329, 841, 10.1126/science.1193032

Gharavi, 2011, Genome-wide association study identifies susceptibility loci for IgA nephropathy., Nat Genet, 43, 321, 10.1038/ng.787

Hurtado, 2005, Hygiene hypothesis and prevalence of glomerulonephritis., Kidney Int Suppl, 68, S62, 10.1111/j.1523-1755.2005.09711.x

McQuarrie, 2014, The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation., Kidney Int, 85, 198, 10.1038/ki.2013.329

Braden, 2000, Changing incidence of glomerular diseases in adults., Am J Kidney Dis, 35, 878, 10.1016/S0272-6386(00)70258-7

Dragovic, 2005, Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns., Clin Nephrol, 63, 1, 10.5414/CNP63001

Haas, 1997, Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997., Am J Kidney Dis, 30, 621, 10.1016/S0272-6386(97)90485-6

Korbet, 1996, The racial prevalence of glomerular lesions in nephrotic adults., Am J Kidney Dis, 27, 647, 10.1016/S0272-6386(96)90098-0

Swaminathan, 2006, Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study., Clin J Am Soc Nephrol, 1, 483, 10.2215/CJN.00710805

Kraus, 2013, Resurgence of membranous nephropathy in African Americans in inner city Chicago., Clin Kidney J, 6, 373, 10.1093/ckj/sft057

Pontier, 1994, Racial differences in the prevalence and presentation of glomerular disease in adults., Clin Nephrol, 42, 79

Murugapandian, 2016, Epidemiology of glomerular disease in southern arizona: Review of 10-year renal biopsy data., Medicine (Baltimore), 95, e3633, 10.1097/MD.0000000000003633

D’Agati, 2004, Pathologic classification of focal segmental glomerulosclerosis: A working proposal., Am J Kidney Dis, 43, 368, 10.1053/j.ajkd.2003.10.024

Ehrenreich, 1968, Pathology of membranous nephropathy., Pathol Annu, 3, 145

Weening, 2004, The classification of glomerulonephritis in systemic lupus erythematosus revisited., Kidney Int, 65, 521, 10.1111/j.1523-1755.2004.00443.x

Servais, 2007, Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome., J Med Genet, 44, 193, 10.1136/jmg.2006.045328

2012, Increasing prevalence of diagnosed diabetes--United States and Puerto Rico, 1995-2010., MMWR Morb Mortal Wkly Rep, 61, 918

Sim, 2016, Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000-2011 among a racially and ethnically diverse US population., Am J Kidney Dis, 68, 533, 10.1053/j.ajkd.2016.03.416

Nair, 2006, Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?, Kidney Int, 69, 1455, 10.1038/sj.ki.5000292

Menke, 2015, Prevalence of and trends in diabetes among adults in the united states, 1988-2012., JAMA, 314, 1021, 10.1001/jama.2015.10029

Pham, 2007, Prevalence of nondiabetic renal disease in diabetic patients., Am J Nephrol, 27, 322, 10.1159/000102598

Feldman, 2013, Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004., Arthritis Rheum, 65, 753, 10.1002/art.37795

Tancredi, 2015, Excess mortality among persons with type 2 diabetes., N Engl J Med, 373, 1720, 10.1056/NEJMoa1504347

Slabaugh, 2015, Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US., J Med Econ, 18, 106, 10.3111/13696998.2014.979292